Clinical Radiology
Volume 65, Issue 9 , Pages 695-700 , September 2010

Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI

  • P.-H. Ducluzeau

      Affiliations

    • Department of endocrinology-Diabetology-Nutrition, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • These authors contribute equally to this work.
    • ,
  • P. Manchec-Poilblanc

      Affiliations

    • Department of Radiology, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • Corresponding Author InformationGuarantor and correspondent: P. Manchec-Poilblanc, Departement de Radiologie, CHU, 49933 Angers Cedex 09, France. Tel.: +33 514 775 1307.
    • These authors contribute equally to this work.
    • ,
  • V. Roullier

      Affiliations

    • Department of Radiology, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • LISA (Laboratoire d'Ingènierie des Systèmes Automatisés), Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • ,
  • E. Cesbron

      Affiliations

    • Department of digestive and liver disease, Universitary hospital of Angers, Faculty of Medicine of Angers, France
    • ,
  • J. Lebigot

      Affiliations

    • Department of Radiology, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • ,
  • S. Bertrais

      Affiliations

    • HIFIH Laboratory, UPRES EA 3859, IFR 132, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • ,
  • C. Aubé

      Affiliations

    • Department of Radiology, Universitary Hospital of Angers, Faculty of Medicine of Angers, France
    • HIFIH Laboratory, UPRES EA 3859, IFR 132, Universitary Hospital of Angers, Faculty of Medicine of Angers, France

Received 1 December 2009 ,Revised 27 February 2010 ,Accepted 10 March 2010.

References 

  1. Cotler SJ, Guzman G, Layden-Almer J, et al. Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging. 2007;25:743–748
  2. Hamer OW, Aguirre DA, Casola G, et al. Fatty liver: imaging patterns and pitfalls. RadioGraphics. 2006;26:1637–1653
  3. Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol. 2006;44:197–208
  4. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8:521–533viii
  5. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047
  6. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med. 2006;6:19–25
  7. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106–1110
  8. Powell EE, Jonsson JR, Clouston AD. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:753–754
  9. Kotronen A, Juurinen L, Tiikkainen M, et al. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology. 2008;135:122–130
  10. Kral JG, Schaffner F, Pierson RN, et al. Body fat topography as an independent predictor of fatty liver. Metabolism. 1993;42:548–551
  11. Poynard T, Ratziu V, Charlotte F, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:34
  12. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33
  13. Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005;4:10
  14. Guiu B, Loffroy R, Petit JM, et al. Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy. Eur Radiol. 2009;19:1786–1793
  15. Illouz F, Roulier V, Rod A, et al. Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome. Diabetes Metab. 2008;34:68–74
  16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845
  17. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474
  18. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  19. Zhang X, Tengowski M, Fasulo L, et al. Measurement of fat/water ratios in rat liver using 3D three-point dixon MRI. Magn Reson Med. 2004;51:697–702
  20. Cassidy FH, Yokoo T, Aganovic L, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. RadioGraphics. 2009;29:231–260
  21. Bahl M, Qayyum A, Westphalen AC, et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology. 2008;249:160–166
  22. Roullier V, Cavaro-Menard C, Guillaume C, et al. Fuzzy algorithms to extract vacuoles of steatosis on liver histological color images. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5575–5578
  23. Qayyum A, Goh JS, Kakar S, et al. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience. Radiology. 2005;237:507–511
  24. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005;237:1048–1055
  25. Cesbron-Métivier E, Jarlot C, Roullier V, et al. Precise and simple quantitation of liver steatosis by MRI in an animal model and in patients with NAFLD. J hepatology. 2009;50(suppl. 1):S255
  26. Thomas EL, Bell JD. Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord. 2003;27:211–218
  27. Ross R, Leger L, Morris D, et al. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol. 1992;72:787–795
  28. Cuchel M, Bloedon LT, Szapary PO, et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med. 2007;356:148–156
  29. Letteron P, Sutton A, Mansouri A, et al. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 2003;38:133–140
  30. Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol. 2001;35:531–537
  31. Buchholz AC, Bugaresti JM. A review of body mass index and waist circumference as markers of obesity and coronary heart disease risk in persons with chronic spinal cord injury. Spinal Cord. 2005;43:513–518
  32. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–1049
  33. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet. 2005;366:1640–1649
  34. Sabir N, Sermez Y, Kazil S, et al. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound. 2001;14:121–128
  35. Nakao K, Nakata K, Ohtsubo N, et al. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol. 2002;97:1796–1801
  36. Fishbein MH, Mogren C, Gleason T, et al. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2006;42:83–88
  37. Pacifico L, Celestre M, Anania C, et al. MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007;96:542–547
  38. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373–379
  39. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35:367–372
  40. Willner IR, Waters B, Patil SR, et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001;96:2957–2961
  41. Samaras K, Wand H, Law M, et al. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Curr HIV Res. 2009;7:454–461
  42. Villena JA, Choi CS, Wang Y, et al. Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes. 2008;57:3258–3266

PII: S0009-9260(10)00186-8

doi: 10.1016/j.crad.2010.03.013

Clinical Radiology
Volume 65, Issue 9 , Pages 695-700 , September 2010

Article Tools

* Image Usage & Resolution